Candriam Equities L Biotech.V2 USD Acc/ LU2026682919 /
| NAV14/05/2024 | Diferencia+4.6600 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 1,814.1400USD | +0.26% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | - | - | - | - | - | 0.79 | -2.58 | 9.54 | 3.06 | - |
| 2021 | 1.89 | -2.53 | -4.20 | 2.79 | -2.19 | 6.44 | -1.39 | 3.98 | -4.17 | 0.23 | -4.31 | 2.49 | -1.66% |
| 2022 | -10.51 | -1.49 | 6.13 | -7.16 | -3.90 | 3.59 | 4.79 | 1.62 | -1.83 | 6.58 | 6.26 | -2.79 | -0.47% |
| 2023 | 3.00 | -5.59 | 0.33 | 2.35 | -0.85 | 1.51 | -0.49 | -0.14 | -4.41 | -6.03 | 6.25 | 13.72 | +8.38% |
| 2024 | 1.58 | 1.43 | 0.05 | -6.16 | 3.94 | - | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 15.91% | 17.31% | 16.25% | 20.08% | -% |
| Índice de Sharpe | -0.15 | 2.01 | 0.11 | 0.01 | - |
| El mes mejor | +13.72% | +13.72% | +13.72% | +13.72% | - |
| El mes peor | -6.16% | -6.16% | -6.16% | -10.51% | - |
| Pérdida máxima | -10.91% | -10.91% | -15.44% | -28.30% | - |
| Rendimiento superior | - | - | - | - | - |
Todas las cotizaciones en USD
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,027.7700 | +5.28% | +9.97% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 216.6400 | +4.76% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,032.3800 | +3.02% | +2.33% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,185.1699 | +5.61% | +22.90% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,381.0500 | +4.56% | +21.43% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 354.6000 | +4.68% | +25.21% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 319.5900 | +5.73% | +25.41% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 197.9800 | +0.67% | +0.69% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,814.1400 | +5.60% | +12.72% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 147.0700 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 590.0200 | +4.04% | +7.79% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,548.6499 | +5.18% | +9.59% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 194.2800 | +2.24% | +1.84% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.5600 | +3.12% | +4.35% | |
| Candriam Equities L Biotech.R US... | reinvestment | 262.9600 | +5.34% | +11.88% | |
| Candriam Equities L Biotechnolo... | reinvestment | 828.1600 | +4.42% | +9.16% | |
| Candriam Equities L Biotechnolog... | paying dividend | 756.3500 | +4.39% | +9.05% |
Performance
| Año hasta la fecha | +0.53% | ||
|---|---|---|---|
| 6 Meses | +17.60% | ||
| Promedio móvil | +5.60% | ||
| 3 Años | +12.72% | ||
| 5 Años | - | ||
| 10 Años | - | ||
| Desde el principio | +20.94% | ||
| Año | |||
| 2023 | +8.38% | ||
| 2022 | -0.47% | ||
| 2021 | -1.66% | ||
